| 000 | 01076 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250517100209.0 | ||
| 264 | 0 | _c20170217 | |
| 008 | 201702s 0 0 eng d | ||
| 022 | _a2374-2445 | ||
| 024 | 7 |
_a10.1001/jamaoncol.2016.0370 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHershman, Dawn L | |
| 245 | 0 | 0 |
_aAdverse Health Effects of Intermittent vs Continuous Androgen Deprivation Therapy for Metastatic Prostate Cancer-Reply. _h[electronic resource] |
| 260 |
_bJAMA oncology _cMay 2016 |
||
| 300 |
_a686-7 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAndrogen Antagonists _xadverse effects |
| 650 | 0 | 4 |
_aAndrogens _xmetabolism |
| 650 | 0 | 4 |
_aDrug-Related Side Effects and Adverse Reactions _xphysiopathology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aNeoplasm Metastasis |
| 650 | 0 | 4 |
_aProstatic Neoplasms _xcomplications |
| 700 | 1 | _aUnger, Joseph M | |
| 773 | 0 |
_tJAMA oncology _gvol. 2 _gno. 5 _gp. 686-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1001/jamaoncol.2016.0370 _zAvailable from publisher's website |
| 999 |
_c26076139 _d26076139 |
||